Marinus Pharmaceuticals reported $40.58M in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 124.48M 1.06M
Amgen AMGN:US $ 33291M 4833M
Aptinyx Inc APTX:US $ 14.04M 14.04M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Biogen BIIB:US $ 6272.3M 996.9M
Eisai 4523:JP Y 49919M 6M
Esperion Therapeutics ESPR:US $ 272.51M 410K
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 40.58M 29.61M
Minerva Neurosciences NERV:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Ptc Therapeutics PTCT:US $ 972.21M 143.17M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Supernus Pharmaceuticals SUPN:US $ 374.79M 4.4M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
YTE INCY:US $ 31.38M 0.46M
Zogenix ZGNX:US $ 155.87M 2.24M